Nitric oxide synthase inhibition by L-NAME in streptozotocin induced diabetic rats: Impacts on oxidative stress

Tohoku Journal of Experimental Medicine

Volumn 199, Issue 4, 2003, Pages 205-210

  Seven, Arzu ^a   Güzel, Savas ^a   Seymen, Oktay ^a   Civelek, Sabiha ^a   Bolayirli, Murat ^a   Yiǧit, Günnur ^a   Burçak, Gülden ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Diabetes; L NAME; Nitric oxide; Oxidative stress

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE SYNTHASE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME INHIBITION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; ERYTHROCYTES; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0042672851     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.199.205     Document Type: Article

References (26)

1. Bank, N. & Aynedjian, H.S. (1993) Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int., 43, 1306-1312.
2. Beutler, E., Duran, O. & Kelly, M. (1963) Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61, 882-888.
3. Braunlich, H., Marx, F. & Stein, G. (1994) Glutathione status, lipid peroxidation and kidney function in streptozotocin diabetic rats. Exp. Toxicol. Pathol., 46, 143-147.
4. Buege, J.A. & Aust, S.D. (1978) Microsomal lipid peroxidation. Methods Enzymol., 52, 302-310.
5. Catanzaro, O.L., Marina-Prendes, M.G., Hope, S.I., Zuccollo, A. & Dominguez, A. (1994) Streptozotocin-induced hyperglycemia is decreased by nitric oxide inhibition. Braz. J. Med. Biol. Res., 27, 2043-2047.
6. Choi, K.C., Lee, S.C., Kim, S.W., Kim, N.H., Lee, J.U. & Kang, Y.J. (1999) Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Korean J. Intern. Med., 14, 32-41.
7. Committee on Care and Use of Laboratory Animals. (1985) Guide for the care and use of laboratory animals. Washington D.C.: Institute of Laboratory Animal Research, National Research Council.
8. Corbett, J.A. & McDaniel, M.L. (1992) Does nitric oxide mediate autoimmune destruction of beta cells ? Possible therapeutic interventions in IDDM. Diabetes, 41, 897-903.
9. Fairbanks, V. & Klee, G.G. (1968) Biochemical aspects of hematology. In: Textbook of Clinical Chemistry, edited by N.W. Tietz, W.B. Saunders, Philadelphia, US, pp. 1532-1534.
10. Feillet-Coudray, C., Rock, E., Coudray, C., Grzelkowska, K.P., Azais-Braesco, V., Dardevet, D. & Mazur, A. (1999) Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta, 284, 31-43.
11. Gonzalez, E., Rosello-Catafau, J., Jawerbaum, A., Sinner, D., Pustovrh, C., Vela, J., White, V., Xaus, C., Peralta, C. & Gimeno, M. (2000) Pancreatic nitric oxide and oxygen free radicals in the early stages of streptozotocin-induced diabetes mellitus in the rat. Braz. J. Med. Biol. Res., 33, 1335-1342.
12. Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wishnok, J.S. & Tannenbaum, S.R. (1982) Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem., 126, 131-138.
13. Haluzik, M., Nedvidkova, J. & Skrha, J. (1999) The influence of methylene blue and L-NAME on the development of streptozotocin-induced diabetes in rats. Sb. Lek., 100, 213-217.
14. Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., Hartmann, M., Skatchkov, M., Thaiss, F., Stahl, R.A.K., Warnholtz, A., Meinertz, T., Griendling, K., Harrison, D.G., Forstermann, U. & Munzel, T. (2001) Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res., 88, 14-22.
15. Hobbs, A.J., Higgs, A. & Moncada, S. (1999) Inhibition of nitric oxide synthase as a potential therapeutic target. Annu. Rev. Pharmacol. Toxicol., 39, 191-220.
16. Kaneto, H., Fujii, J., Seo, H.G., Suzuki, K., Matsuoka, T., Nakamura, M., Tatsumi, H., Yamasaki, Y., Kamada, T. & Taniguchi, N. (1995) Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes, 44, 733-738.
17. Kolb, H. & Kolb-Bachofen, V. (1992) Type 1 (insulin-dependent) diabetes mellitus and nitric oxide. Diabetologia, 35, 796-797.
18. Komers, R., Allen, T.J. & Cooper, M.E. (1994) Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes, 43, 1190-1197.
19. Maree, A., Peer, G., Iaina, A., Blum, M., Wollman, Y., Csernihovsky, T., Silverberg, D.S. & Cabill, S. (1996) Nitric oxide in streptozotocin-induced diabetes mellitus in rats. Clin. Sci., 90, 379-384.
20. McDaniel, M.L., Kwon, G., Hill, J.R., Marshall, C.A. & Corbett, J.A. (1996) Cytokines and nitric oxide in islet inflammation and diabetes. Proc. Soc. Exp. Biol. Med., 211, 24-32.
21. Moshage, H., Kok, B., Huizenga, J.R. & Jansen, P.L. (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem., 41, 892-896.
22. Mukherjee, B., Anbazhagan, S., Roy, A., Ghosh, R. & Chatterjee, M. (1998) Novel implications of the potential role of selenium on antioxidant status in streptozotocin-induced diabetic mice. Biomed. Pharmacother, 52, 89-95.
23. Paglia, D.E. & Valentine, W.N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70, 158-169.
24. Shull, S., Heintz, N.H., Periosery, M., Manoha, M., Johnssen, Y.M. & Marsh, J.P. (1991) Differential regulation of antioxidant enzymes in response to antioxidant. J. Biol. Chem., 266, 24398-24464.
25. Stevens, R.B., Sutherland, D.E., Ansite, J.D., Saxena, M., Rossini, T.J., Levay-Young, B.K., Hering, B.J. & Mills, C.D. (1997) Insulin down-regulates the inducible nitric oxide synthase pathway: nitric oxide as cause and effect of diabetes. J. Immunol., 159, 5329-5335.
26. Sun, Y., Oberley, L.W. & Li, Y. (1988) A simple method for clinical assay of superoxide dismutase. Clin. Chem., 34, 497-500.